CORCEPT THERAPEUTICS INC (CORT)

SEC filing

CORCEPT THERAPEUTICS INC

CORT · CIK 1088856

4 · Dec 3, 2025 · Mokari Atabak was granted 356 shares at $39.89/share ($14,201); reported 118 shares

Mokari Atabak was granted 356 shares at $39.89/share ($14,201); reported 118 shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.